Do analysts prefer DYNT or VRAX?

Virax Biolabs Group has a consensus target price of $25.00, suggesting a potential upside of 738.93%. Given Virax Biolabs Group's stronger consensus rating and higher probable upside, analysts clearly believe Virax Biolabs Group is more favorable than Dynatronics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Virax Biolabs Group 1 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has higher valuation & earnings, DYNT or VRAX?

Dynatronics has higher revenue and earnings than Virax Biolabs Group. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Dynatronics $33.60M 0.00 -$2.70M -$1.35 N/A Virax Biolabs Group $10K 238.40 -$5.02M N/A N/A

Do analysts prefer DYNT or TNON?

Given Dynatronics' higher possible upside, equities analysts plainly believe Dynatronics is more favorable than Tenon Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Tenon Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Is DYNT or TNON more profitable?

Dynatronics has a net margin of -8.35% compared to Tenon Medical's net margin of -270.09%. Dynatronics' return on equity of -41.81% beat Tenon Medical's return on equity. Company Net Margins Return on Equity Return on Assets Dynatronics -8.35% -41.81% -9.56% Tenon Medical -270.09% -907.60% -110.17%

Do analysts rate FEED or DYNT?

Given Dynatronics' higher possible upside, analysts plainly believe Dynatronics is more favorable than Nanovibronix. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nanovibronix 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Is BTCY or DYNT more profitable?

Dynatronics has a net margin of -8.35% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Dynatronics' return on equity. Company Net Margins Return on Equity Return on Assets Biotricity -80.42% N/A -188.47% Dynatronics -8.35% -41.81% -9.56%

Do analysts prefer BBLG or DYNT?

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Bone Biologics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bone Biologics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Dynatronics (DYNT) Competitors

Compare

DYNT vs. VRAX, TNON, FEED, BTCY, and BBLG

Should you buy Dynatronics stock or one of its competitors? MarketBeat compares Dynatronics with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Dynatronics include Virax Biolabs Group (VRAX), Tenon Medical (TNON), Nanovibronix (FEED), Biotricity (BTCY), and Bone Biologics (BBLG). These companies are all part of the "healthcare equipment" industry.

How does Dynatronics compare to Virax Biolabs Group?

Dynatronics (NASDAQ:DYNT) and Virax Biolabs Group (NASDAQ:VRAX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

Dynatronics has higher revenue and earnings than Virax Biolabs Group.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Virax Biolabs Group	$10K	238.40	-$5.02M	N/A	N/A

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 8.6% of Virax Biolabs Group shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by insiders. Comparatively, 45.1% of Virax Biolabs Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Virax Biolabs Group has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Virax Biolabs Group's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Virax Biolabs Group	N/A	N/A	N/A

In the previous week, Virax Biolabs Group's average media sentiment score of 0.59 beat Dynatronics' score of 0.00 indicating that Virax Biolabs Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Dynatronics	Neutral
Virax Biolabs Group	Positive

Virax Biolabs Group has a consensus target price of $25.00, suggesting a potential upside of 738.93%. Given Virax Biolabs Group's stronger consensus rating and higher probable upside, analysts clearly believe Virax Biolabs Group is more favorable than Dynatronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Virax Biolabs Group	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Dynatronics has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Virax Biolabs Group has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market.

Summary

Virax Biolabs Group beats Dynatronics on 10 of the 12 factors compared between the two stocks.

How does Dynatronics compare to Tenon Medical?

Dynatronics (NASDAQ:DYNT) and Tenon Medical (NASDAQ:TNON) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Given Dynatronics' higher possible upside, equities analysts plainly believe Dynatronics is more favorable than Tenon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Tenon Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Tenon Medical had 2 more articles in the media than Dynatronics. MarketBeat recorded 2 mentions for Tenon Medical and 0 mentions for Dynatronics. Dynatronics' average media sentiment score of 0.00 beat Tenon Medical's score of -0.67 indicating that Dynatronics is being referred to more favorably in the media.

Company	Overall Sentiment
Dynatronics	Neutral
Tenon Medical	Negative

Dynatronics has a net margin of -8.35% compared to Tenon Medical's net margin of -270.09%. Dynatronics' return on equity of -41.81% beat Tenon Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Dynatronics	-8.35%	-41.81%	-9.56%
Tenon Medical	-270.09%	-907.60%	-110.17%

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 22.7% of Tenon Medical shares are owned by institutional investors. 2.9% of Dynatronics shares are owned by company insiders. Comparatively, 17.7% of Tenon Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Dynatronics has a beta of 0.31, suggesting that its share price is 69% less volatile than the broader market. Comparatively, Tenon Medical has a beta of 1.39, suggesting that its share price is 39% more volatile than the broader market.

Dynatronics has higher revenue and earnings than Tenon Medical. Tenon Medical is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A
Tenon Medical	$3.94M	0.39	-$12.56M	-$1.29	N/A

Summary

Dynatronics beats Tenon Medical on 8 of the 15 factors compared between the two stocks.

How does Dynatronics compare to Nanovibronix?

Nanovibronix (NASDAQ:FEED) and Dynatronics (NASDAQ:DYNT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

Given Dynatronics' higher possible upside, analysts plainly believe Dynatronics is more favorable than Nanovibronix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nanovibronix	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

16.4% of Nanovibronix shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 12.2% of Nanovibronix shares are held by company insiders. Comparatively, 2.9% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Nanovibronix has a beta of 1.38, suggesting that its stock price is 38% more volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Dynatronics has higher revenue and earnings than Nanovibronix. Nanovibronix is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nanovibronix	$2.18M	1.12	-$18.18M	-$8.82	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

In the previous week, Nanovibronix had 2 more articles in the media than Dynatronics. MarketBeat recorded 2 mentions for Nanovibronix and 0 mentions for Dynatronics. Nanovibronix's average media sentiment score of 0.66 beat Dynatronics' score of 0.00 indicating that Nanovibronix is being referred to more favorably in the media.

Company	Overall Sentiment
Nanovibronix	Positive
Dynatronics	Neutral

Dynatronics has a net margin of -8.35% compared to Nanovibronix's net margin of -923.20%. Dynatronics' return on equity of -41.81% beat Nanovibronix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nanovibronix	-923.20%	-54.25%	-43.10%
Dynatronics	-8.35%	-41.81%	-9.56%

Summary

Dynatronics beats Nanovibronix on 8 of the 14 factors compared between the two stocks.

How does Dynatronics compare to Biotricity?

Biotricity (NASDAQ:BTCY) and Dynatronics (NASDAQ:DYNT) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, risk, earnings, valuation, institutional ownership and dividends.

In the previous week, Biotricity's average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score.

Company	Overall Sentiment
Biotricity	Neutral
Dynatronics	Neutral

Biotricity has a beta of 1.13, suggesting that its stock price is 13% more volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, suggesting that its stock price is 69% less volatile than the broader market.

Dynatronics has a net margin of -8.35% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Dynatronics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biotricity	-80.42%	N/A	-188.47%
Dynatronics	-8.35%	-41.81%	-9.56%

3.9% of Biotricity shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 1.6% of Biotricity shares are held by insiders. Comparatively, 2.9% of Dynatronics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Dynatronics has higher revenue and earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biotricity	$12.06M	0.18	-$14.09M	-$0.12	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

Summary

Dynatronics beats Biotricity on 7 of the 10 factors compared between the two stocks.

How does Dynatronics compare to Bone Biologics?

Bone Biologics (NASDAQ:BBLG) and Dynatronics (NASDAQ:DYNT) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, risk, profitability, dividends, earnings and media sentiment.

In the previous week, Bone Biologics had 1 more articles in the media than Dynatronics. MarketBeat recorded 1 mentions for Bone Biologics and 0 mentions for Dynatronics. Bone Biologics' average media sentiment score of 0.00 equaled Dynatronics'average media sentiment score.

Company	Overall Sentiment
Bone Biologics	Neutral
Dynatronics	Neutral

Given Dynatronics' higher probable upside, analysts clearly believe Dynatronics is more favorable than Bone Biologics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bone Biologics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Dynatronics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Bone Biologics has a beta of 0.92, indicating that its stock price is 8% less volatile than the broader market. Comparatively, Dynatronics has a beta of 0.31, indicating that its stock price is 69% less volatile than the broader market.

34.3% of Bone Biologics shares are owned by institutional investors. Comparatively, 4.2% of Dynatronics shares are owned by institutional investors. 5.6% of Bone Biologics shares are owned by insiders. Comparatively, 2.9% of Dynatronics shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Bone Biologics has a net margin of 0.00% compared to Dynatronics' net margin of -8.35%. Dynatronics' return on equity of -41.81% beat Bone Biologics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bone Biologics	N/A	-50.47%	-47.40%
Dynatronics	-8.35%	-41.81%	-9.56%

Dynatronics has higher revenue and earnings than Bone Biologics. Bone Biologics is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bone Biologics	N/A	N/A	-$3.11M	-$2.27	N/A
Dynatronics	$33.60M	0.00	-$2.70M	-$1.35	N/A

Summary

Dynatronics beats Bone Biologics on 7 of the 13 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

DYNT vs. The Competition

Export

Metric	Dynatronics	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$653K	$5.82B	$7.02B	$13.00B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-0.01	24.26	271.11	25.19
Price / Sales	N/A	62.05	590.37	78.11
Price / Cash	N/A	33.10	71.81	50.72
Price / Book	N/A	5.70	13.25	6.22
Net Income	-$2.70M	$148.58M	$3.45B	$342.66M

Dynatronics Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
DYNT Dynatronics	N/A	N/A	N/A	N/A	$653K	$33.60M	N/A	200
VRAX Virax Biolabs Group	2.3426 of 5 stars	$2.91 -2.4%	$25.00 +759.4%	-84.8%	$2.33M	$10K	N/A	5
TNON Tenon Medical	1.2005 of 5 stars	$0.19 +0.8%	N/A	-90.6%	$2.31M	$3.94M	N/A	8	News Coverage Upcoming Earnings
FEED Nanovibronix	0.9376 of 5 stars	$0.37 -1.1%	N/A	N/A	$2.24M	$2.55M	N/A	20
BTCY Biotricity	N/A	$0.11 flat	N/A	-76.2%	$2.13M	$12.06M	N/A	40	Upcoming Earnings Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:DYNT) was last updated on 8/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Dynatronics (DYNT) Competitors

DYNT vs. VRAX, TNON, FEED, BTCY, and BBLG

How does Dynatronics compare to Virax Biolabs Group?

Summary

How does Dynatronics compare to Tenon Medical?

Summary

How does Dynatronics compare to Nanovibronix?

Summary

How does Dynatronics compare to Biotricity?

Summary

How does Dynatronics compare to Bone Biologics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT vs. The Competition

Dynatronics Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Dynatronics (DYNT) Competitors

DYNT vs. VRAX, TNON, FEED, BTCY, and BBLG

How does Dynatronics compare to Virax Biolabs Group?

Which has higher valuation & earnings, DYNT or VRAX?

Do institutionals & insiders have more ownership in DYNT or VRAX?

Is DYNT or VRAX more profitable?

Does the media refer more to DYNT or VRAX?

Do analysts prefer DYNT or VRAX?

Which has more volatility & risk, DYNT or VRAX?

Summary

How does Dynatronics compare to Tenon Medical?

Do analysts prefer DYNT or TNON?

Does the media refer more to DYNT or TNON?

Is DYNT or TNON more profitable?

Do insiders & institutionals hold more shares of DYNT or TNON?

Which has more risk and volatility, DYNT or TNON?

Which has preferable earnings and valuation, DYNT or TNON?

Summary

How does Dynatronics compare to Nanovibronix?

Do analysts rate FEED or DYNT?

Do institutionals & insiders believe in FEED or DYNT?

Which has more risk & volatility, FEED or DYNT?

Which has stronger earnings and valuation, FEED or DYNT?

Does the media prefer FEED or DYNT?

Is FEED or DYNT more profitable?

Summary

How does Dynatronics compare to Biotricity?

Does the media prefer BTCY or DYNT?

Which has more risk & volatility, BTCY or DYNT?

Is BTCY or DYNT more profitable?

Do insiders & institutionals hold more shares of BTCY or DYNT?

Which has better valuation & earnings, BTCY or DYNT?

Summary

How does Dynatronics compare to Bone Biologics?

Does the media prefer BBLG or DYNT?

Do analysts prefer BBLG or DYNT?

Which has more volatility and risk, BBLG or DYNT?

Do institutionals and insiders hold more shares of BBLG or DYNT?

Is BBLG or DYNT more profitable?

Which has preferable valuation & earnings, BBLG or DYNT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

DYNT vs. The Competition

Dynatronics Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools